Investigation of the course proinflammatory and anti-inflammatory cytokines after burn sepsis

International Journal of Clinical Practice

Volumn 58, Issue 2, 2004, Pages 125-129

  Ozbalkan, Z ^a   Aslar, A Kessaf ^a,b   Yildiz, Y ^a   Aksaray, S ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Anti inflammatory cytokines; Burn sepsis; IL 10; IL 8; Proinflammatory cytokines

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 8;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BURN; BURN INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; MORTALITY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT PLANNING; TURKEY (REPUBLIC);

ADULT; BURNS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; MALE; MIDDLE AGED; PROGNOSIS; SEPSIS;

EID: 1842434288     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2004.0106.x     Document Type: Article

References (40)

1. Salvo I, de Cian W, Mussico M et al. The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995; 21: 244-9.
2. Blackwell TS, Christman JW. Sepsis and cytokines: Current status. Br J Anaesth 1996; 77: 110-7.
3. Damas P, Ledoux D, Nys M et al. Cytokine serum level-during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215: 356-62.
4. Montegut W, Lowry SF, Moldawer LL. Role of cytokines in septic shock and shock-related syndromes. In: Aggarwal BB, Puri RK, eds. Human Cytokines: Their Role in Disease and Therapy Cambridge, MA: Blackwell Science, 1995: 381-9.
5. Youn YK, LaLonde C, Demling R. The role of mediators in the response to thermal injury. World J Surg 1992; 16: 30-6.
6. Arturson G. Pathophysiology of the burn wound and pharmacological treatment. Burns 1996; 22: 255-74.
7. Marty C, Misset B, Tamion F et al. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994; 22: 673-9.
8. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106-13.
9. Tracey KJ, Beutler B, Lowry SF et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-4.
10. Holmadahl L, Ivarsson ML. The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair. Eur J Surg 1999; 165: 1012-9.
11. Schlag G, Redl H. Mediators of injury and inflammation. World J Surg 1996; 20: 406-10.
12. Martin C, Boisson C, Haccoun M et al. Pattern of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997; 25: 1813-9.
13. Van der Poll T, Deventer SJH. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 1999; 13: 413-26.
14. Greenberger MJ, Kunkel SI, Strieter RM et al. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol 1996; 157: 3006-12.
15. Van der Poll T, Keogh CV, Guirao X et al. Interleukin-6 gene deficient mice show impaired defense against streptococcal pneumonia. J Infect Dis 1997; 176: 439-44.
16. Vindenes H, Ulvestad E, Bjerknes R. Increased levels of circulating interleukin 8 in patients with large burns: Relation to burn size and sepsis. J Trauma 1995; 39: 635-40.
17. Rodriquez JL, Miller CG, Garner WI et al. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993; 34: 684-95.
18. Hack CE, Hart M, Strack van Schijndel RJ et al. Interleukin 8 in sepsis: Relation to shock and inflammatory mediators. Infect Immun 1991; 60: 2835-42.
19. Haupt W, Zirngibl H, Stehr A et al. Tumor necrosis factor-α and interleukin-10 production in septic patients and regulatory effect of plasma. Eur J Surg 1999; 165: 95-100.
20. Furuzawa-Carbellada J, Alcocer-Varela J. Interleukin-8, interleukin 10, intercellular adhesion molecule-1 expression levels are higher in synovial tissue from patients with rheumatoid arthritis than in osteoarthritis. Scand J Immunol 1999; 50: 215-22.
21. Goldman M, Velu T. Interleukin-10 and its implications for immunopathology. Adv Nephrol 1995; 24: 79-90.
22. Yeh FL, Lin WL, Shen HD. Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients. Burns 2000; 26: 454-9.
23. van Deuren M, van der Ven-Jongekrijg J, Bartelink AKM et al. Correlation between proinflammatory cytokines and antiinflammatory mediators and severity of disease in meningococcal infections. J Infect Dis 1994; 172: 433-9.
24. Sherry RM, Cue JI, Goddard JK et al. Interleukin 10 is associated with the development of sepsis in trauma patients. J Trauma 1996; 40: 613-6.
25. American Collage of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 20: 864-974.
26. Dalton HJ. T-cell responses in burn infections. Crit Care Med 2001; 29: 2386-7.
27. Patel RT, Deen KI, Youngs D et al. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994; 81: 1306-8.
28. Vindenes HA, Ulvested E, Bjerknes R. Concentrations of cytokines in plasma of patients with large burns: Their relation to time after injury, burn size, inflammatory variables, infection, and outcome. Eur J Surg 1998; 164: 647-56.
29. Drost AC, Burleson DG, Cioffi WG et al. Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma 1993; 35: 335-9.
30. Kowal-Vern A, Walenga JM, Hoppensteadt D et al. Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury. J Am Coll Surg 1994; 178: 357-62.
31. Xia ZF, Coolbaugh MI, He F et al. The effects of burn injury on the acute phase response. J Trauma 1992; 32: 245-50.
32. Dehne MG, Sablotzki A, Hoffman A et al. Alterations of acute phase reaction and cytokine production in patients following severe burn injury. Burns 2002; 28: 535-42.
33. Latha B, Ramakrishan KM, Jayaraman V, Babu M. Action of trypsin: Chymotrypsin (chymoral forte DS) preparation on acute-phase proteins following burn injury in humans. Burns 1997; 23 (Suppl. 1): S3-7.
34. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 293-301.
35. Wong DT, Barrow PM, Gomez M, McGuire GP. A comparison of the acute physiology and chronic health evaluation (APACHE) II score and the Trauma Injury Severity Score (TRISS) for outcome assessment in intensive care unit trauma patients. Crit Care Med 1996; 24: 1642-8.
36. Moss M, Bucher B, Moore FA et al. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996; 275: 50-4.
37. Wang BW, Mok KT, Chang HT et al. APACHE II score: A useful tool for risk assessment and an aid to decision-making in emergency operation for bleeding gastric ulcer. J Am Coll Surg 1998; 187: 287-94.
38. Burger T, Meyer F, Tautenhahn J, Halloul I. Ruptured infrarenal aortic aneurysm - a critical evaluation. Vasa 1999; 28: 30-3.
39. Carraro Setti FG, Magenta A, Segala M et al. Predictive value of a pathophysiological score in the surgical treatment of perforated diverticular disease. Chr Ital 1999; 51: 31-6.
40. Rutledge R, Fakhry S, Rutherford E et al. Comparison of APACHE II; trauma score and injury severity score as predictors of outcome in critically injured trauma patients. Am J Surg 1993; 166: 244-7.